Keybanc Initiates Coverage On Steris with Overweight Rating, Announces Price Target of $253
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Brett Fishbin has initiated coverage on Steris (NYSE:STE) with an Overweight rating and set a price target of $253.
February 06, 2024 | 12:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Steris receives an Overweight rating from Keybanc with a price target of $253.
The initiation of coverage by Keybanc with an Overweight rating and a high price target suggests a bullish outlook for Steris. This is likely to generate positive investor sentiment and could lead to a short-term increase in the stock price, given the credibility of Keybanc's analysis and the specific financial target provided.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100